financetom
Business
financetom
/
Business
/
Wall Street bankers say merger outlook has already jumped in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wall Street bankers say merger outlook has already jumped in 2025
Jan 14, 2025 1:53 PM

MIAMI (Reuters) - Wall Street bankers are already upbeat about a revival in mergers and acquisitions this year that will buoy broader investment banking activity.

It may take some time for deals to materialize, but buyouts including bank deals could gain momentum in the second half of 2025.

Here are quotes from the Frontiers of Digital Finance conference in Miami:

AVINASH MEHROTRA, CO-HEAD OF M&A AMERICAS, GOLDMAN SACHS ( GS ):

You have four banks that have over a trillion dollars in assets. I think there's an expectation that the regulators would welcome at least another one or two in that stratosphere, so that we've got an environment where we have more competition.

But I think we are going to see the most activity in the regional bank space, which would include banks that are under $100 billion in assets.

On the timing, it is going to start a bit slower, but will pick up pace.

DAVID MACGOWN, MANAGING DIRECTOR AT BARCLAYS ( JJCTF ):

M&A activity has picked up markedly post-elections. There are a host of reasons driving the pent-up demand from what has been a couple of years of market turmoil across financial institutions, less sponsors and some skewed ratios.

Now there's pent-up demand for deals to get done. There are more deals in the market now, more assets for sale, but threading the needle and trying to get things done is challenging.

JEFFREY LEVINE, GLOBAL CO-HEAD OF FINANCIAL SERVICES AT HOULIHAN LOKEY ( HLI ):

More capital has been raised in the last three years than in the history of private equity, but it hasn't been deployed.

There's definitely been a mismatch between buying and selling and a lot has to do with interest rate environment and credit conditions, but that is shifting now.

We are seeing more activity in the markets. We have more deals already coming into the market in 2025 than we had in the last two years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Feb 3, 2025
03:10 AM EST, 02/03/2025 (MT Newswires) -- Eric P Lefkofsky, 10% Owner, Director, Chief Executive Officer and Chairman, on January 29, 2025, sold 238,800 Class A common shares in Tempus AI ( TEM ) for $13,278,632. Following the Form 4 filing with the SEC, Lefkofsky has control over a total of 48,757,318 shares of the company, with 5,532,987 shares held...
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Feb 3, 2025
03:09 AM EST, 02/03/2025 (MT Newswires) -- Steven Leonard Chapman, Director, Chief Executive Officer and President, on January 29, 2025, sold 13,685 common shares in Natera ( NTRA ) for $2,269,928. Following the Form 4 filing with the SEC, Chapman has control over a total of 253,944 shares of the company, with 253,944 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1604821/000141588925002621/xslF345X05/form4-01312025_090101.xml ...
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
Feb 3, 2025
ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its over-the-counter Nuance audio glasses. Nuance - which pairs hearing solutions with prescription glasses - will be available in the U.S. and in Italy in the first quarter of the year and in other European countries, including France, Germany...
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Feb 3, 2025
03:12 AM EST, 02/03/2025 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President, Research & Development, Chief Medical Officer, on January 30, 2025, sold 100,918 ordinary shares in Alkermes ( ALKS ) for $3,234,382. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 44,290 shares of the company, with 44,290 shares held directly. SEC...
Copyright 2023-2025 - www.financetom.com All Rights Reserved